From: Using neural networks to support high-quality evidence mapping
Class | Precision | Recall | F1 |
---|---|---|---|
Diagnosis | 0.78 (0.05) | 0.58 (0.03) | 0.67 (0.01) |
Etiology | 0.70 (0.03) | 0.47 (0.06) | 0.56 (0.03) |
Experiences and perceptions; consequences; social, political, economic aspects | 0.77 (0.11) | 0.40 (0.05) | 0.51 (0.02) |
Infection prevention and control | 0.53 (0.09) | 0.19 (0.06) | 0.28 (0.08) |
Interventions targeted at system level | 0.59 (0.07) | 0.11 (0.08) | 0.16 (0.12) |
Interventions to treat the infected patient | 0.76 (0.05) | 0.29 (0.04) | 0.41 (0.03) |
Prevalence and incidence | 0.54 (0.00) | 0.28 (0.17) | 0.34 (0.15) |
Prognosis | 0.67 (0.02) | 0.55 (0.05) | 0.61 (0.02) |